Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy does not directly cause ketosis. Semaglutide works by mimicking a gut hormone called GLP-1, which reduces appetite and slows gastric emptying — it has no mechanism that pushes your body into fat-burning ketosis on its own. If ketosis appears while you're taking Wegovy, it's almost certainly because you're eating significantly less and your carbohydrate intake has dropped as a result, not because the medicine itself triggered it. That distinction matters for how you plan your diet, manage your energy, and interpret any symptoms. As a prescription-only medicine, Wegovy requires a clinical assessment before a prescriber can decide whether it's appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've started Wegovy, you're a few weeks in, and meals that used to disappear in minutes are sitting half-eaten. Rice, bread, pasta, you're just not getting to them. Your overall calorie intake has dropped sharply, and with it, your carbohydrate consumption. That's the moment people start noticing something: a faint fruity or metallic taste in the mouth, a dip in energy in the early afternoon, urine that smells different. A quick check with a supermarket ketone strip (dip it, wait fifteen seconds) comes back with a faint pink band. So, is Wegovy causing ketosis?
Not directly. Semaglutide, the active ingredient in Wegovy, binds to GLP-1 receptors in the brain and gut. It makes you feel full faster, delays the stomach emptying, and reduces cravings for high-calorie foods. None of that is a metabolic switch to ketosis. What's happening is simpler: when total food intake falls far enough and carbohydrate intake drops below roughly 50g a day (which is easy to do accidentally when you're eating a third of your usual portion) the liver starts converting fat into ketone bodies as a backup fuel. That's ketosis. Wegovy created the conditions for it by suppressing appetite, but the medicine itself didn't flip the switch. The NHS medicines page for semaglutide describes how the medicine works without mentioning ketosis, because it isn't part of semaglutide's mechanism. For a broader look at how semaglutide affects weight, the Wegovy overview at nume covers the licensed indications and trial evidence.
For most people, drifting into mild nutritional ketosis while on Wegovy is unremarkable. It tends to happen in the first few months when appetite suppression is strongest and eating patterns are most disrupted. Symptoms (that metallic breath, a brief energy dip, slightly increased thirst) are usually mild and self-limiting. They can, however, overlap with Wegovy's own common side effects: nausea, fatigue, and headache are all reported during dose escalation, as detailed in NICE's appraisal of semaglutide for weight management. Separating the two isn't always easy. If you're unsure whether what you're experiencing is ketosis or a medication effect, that's worth a message to your prescriber rather than a self-diagnosis from a forum.
There's one situation that does warrant more attention: diabetic ketoacidosis (DKA). DKA is a serious, distinct condition associated with poorly controlled type 2 diabetes, not with Wegovy used for weight management in non-diabetic patients. If Wegovy has been prescribed alongside insulin or other diabetes medication, speak to your GP or specialist before making significant dietary changes. Ketone levels in that context are not the same low-level, benign readings you'd see from simply eating less bread. Some patients also ask about keto breath specifically; if that's your main question, this page on Wegovy and breath changes goes through the different causes.
Some people deliberately follow a ketogenic diet while taking Wegovy, reasoning that both approaches suppress appetite and promote fat loss. That logic isn't wrong, but there are practical considerations. First, GI side effects (nausea, reflux, diarrhoea) are already common in the early months of Wegovy treatment. A strict ketogenic diet, particularly one high in fat, can worsen nausea and slow gastric emptying further (Wegovy already does this). Managing fat intake carefully during the titration phase tends to be more comfortable than going full-keto on day one.
Second, rapid weight loss from combining both approaches can increase the risk of gallstone formation, a known consideration with GLP-1 medicines. Third, electrolyte balance needs watching: both ketogenic diets and semaglutide's diuretic-adjacent effects on fluid can shift sodium, potassium, and magnesium levels. None of this means the combination is off-limits. It means it should be a conversation with your prescriber before you start, not an experiment you run solo. For practical guidance on food choices that tend to work well on Wegovy, our food guide covers the evidence-based basics. If you're weighing up how deliberate keto might interact with the treatment, this page on doing keto alongside Wegovy looks at it in more detail, and our page on fatty foods and Wegovy covers the tolerance side of the fat question.
The cost of a private Wegovy prescription is a real consideration for many people; our guide to Wegovy pricing in the UK puts the market context honestly. When you're ready to talk through whether Wegovy is suitable for your situation, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.